Pure Global
Singapore HSA registration DE0507541

DiaSorin LIAISON VZV IgG

Singapore flagSingapore·CLASS B IVD·DiaSorin Italia S.p.A.·Registered November 25, 2022
Device classification
Device Class
CLASS B IVD
Medical Speciality Area
Immunology
Registration information
Registration Number
DE0507541
Registration Date
November 25, 2022
Change Notification Approval Date
February 13, 2025
Retention Due Date
November 24, 2025
Product description
The LIAISON® VZV IgG assay uses chemiluminescence immunoassay (CLIA) technology for the quantitative determination of specific IgG antibodies to varicella-zoster virus (VZV) in human serum samples. The test has to be performed on the LIAISON® Analyzer family
Product Owner
Name
DiaSorin Italia S.p.A.
Short Name
DiaSorin Italia S.p.A.
Address
Via Crescentino, snc, 13040 Saluggia (VC) Italy, ITALY
Registrant
Name
SPD SCIENTIFIC PTE LTD
Address
100H PASIR PANJANG ROAD, OC@PASIR PANJANG, #07-01, SINGAPORE 118524
Importer
Name
SPD SCIENTIFIC PTE LTD
Address
100H PASIR PANJANG ROAD, OC@PASIR PANJANG, #07-01, SINGAPORE 118524
Model information
Model Name(s)
LIAISON VZV IgG LIAISON® Control VZV IgG
Model Identifier(s)
310850 310851
About this record

Access comprehensive regulatory information for DiaSorin LIAISON VZV IgG in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0507541 and owned by DiaSorin Italia S.p.A.. The device was registered on November 25, 2022.

This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.

Free DatabasePowered by Pure Global AIHSA Official DataCLASS B IVD